Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Kalland

Showing results (31-40 of 122) with videos related to

Pageof 13
Sort By:
Journal of the National Cancer Institute|August 1, 1979
Long-term effects of neonatal estrogen treatment on mitogen responsiveness of mouse spleen lymphocytesT Kalland, O Strand, J G Forsberg
Cancer Immunology, Immunotherapy : CII|August 1, 1995
Enhanced and prolonged efficacy of superantigen-induced cytotoxic T lymphocyte activity by interleukin-2 in vivoH Belfrage, M Dohlsten, G Hedlund, et al.
Immunology|February 1, 1997
Prevention of superantigen-induced down-regulation of T-cell mediated cytotoxic activity by IL-2 in vivoH Belfrage, M Dohlsten, G Hedlund, et al.
Endocrinology|December 1, 1976
The content of a specific cell product in the vaginal epithelium of normal and neonatally estrogenized mice: its dependence on an estradiol-prolactin interactionT Kalland, S O Døskeland, J G Forsberg
European Neurology|January 1, 1985
A study of some immunological variables in twins, discordant for multiple sclerosisA Heltberg, T Kalland, B Källén, et al.
Obstetrics and Gynecology|April 1, 1978
Localization of 3H-estradiol-17beta in diethylstilbestrol-induced adenosisT Kalland, T M Fossberg, J G Forsberg
Endocrine Research Communications|January 1, 1980
Long-term effects of neonatal DES treatment on plasma prolactin in female miceT Kalland, J G Forsberg, Y N Sinha
Cancer Immunology, Immunotherapy : CII|April 1, 1997
Prevention of superantigen-induced tolerance in vivo by interleukin-2 treatmentH Belfrage, M Dohlsten, G Hedlund, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1993
Superantigen-based tumor therapy: in vivo activation of cytotoxic T cellsG Hedlund, M Dohlsten, C Petersson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1987
Analysis of the murine lymphokine-activated killer (LAK) cell phenomenon: dissection of effectors and progenitors into NK- and T-like cellsT Kalland, H Belfrage, P Bhiladvala, et al.
Pageof 13

Showing results (31-40 of 122) with videos related to

Sort By:
Pageof 13
Journal of the National Cancer Institute|August 1, 1979
Long-term effects of neonatal estrogen treatment on mitogen responsiveness of mouse spleen lymphocytesT Kalland, O Strand, J G Forsberg
Cancer Immunology, Immunotherapy : CII|August 1, 1995
Enhanced and prolonged efficacy of superantigen-induced cytotoxic T lymphocyte activity by interleukin-2 in vivoH Belfrage, M Dohlsten, G Hedlund, et al.
Immunology|February 1, 1997
Prevention of superantigen-induced down-regulation of T-cell mediated cytotoxic activity by IL-2 in vivoH Belfrage, M Dohlsten, G Hedlund, et al.
Endocrinology|December 1, 1976
The content of a specific cell product in the vaginal epithelium of normal and neonatally estrogenized mice: its dependence on an estradiol-prolactin interactionT Kalland, S O Døskeland, J G Forsberg
European Neurology|January 1, 1985
A study of some immunological variables in twins, discordant for multiple sclerosisA Heltberg, T Kalland, B Källén, et al.
Obstetrics and Gynecology|April 1, 1978
Localization of 3H-estradiol-17beta in diethylstilbestrol-induced adenosisT Kalland, T M Fossberg, J G Forsberg
Endocrine Research Communications|January 1, 1980
Long-term effects of neonatal DES treatment on plasma prolactin in female miceT Kalland, J G Forsberg, Y N Sinha
Cancer Immunology, Immunotherapy : CII|April 1, 1997
Prevention of superantigen-induced tolerance in vivo by interleukin-2 treatmentH Belfrage, M Dohlsten, G Hedlund, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1993
Superantigen-based tumor therapy: in vivo activation of cytotoxic T cellsG Hedlund, M Dohlsten, C Petersson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1987
Analysis of the murine lymphokine-activated killer (LAK) cell phenomenon: dissection of effectors and progenitors into NK- and T-like cellsT Kalland, H Belfrage, P Bhiladvala, et al.
Pageof 13